Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 26Prostatic Neoplasms 5Stomach Neoplasms 3Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Ifosfamide 6Paclitaxel 5Filgrastim 5Carboplatin 5Etoposide 4Cisplatin 4pegfilgrastim 3Granulocyte Colony-Stimulating Factor 3Thiotepa 2Mesna 2Brentuximab Vedotin 2Bleomycin 2sargramostim 1pegylated granulocyte colony-stimulating factor 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Therapeutics 1Taxes 1Sunitinib 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Interleukin-11 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Embryonal × ixabepilone × Clear all
NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
29 enrolled
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡